Cepharanthine was found to inhibit angiogenesis and growth of human oral squamous cell carcinoma OSCC cells by inhibiting the expression of VEGF and IL-8, and blocking NF-κB activity [80]. The gene discussed is NFKB1; the disease is oral cavity squamous cell carcinoma.